期刊文献+

改良的橘皮果胶抑制半乳糖凝集素-3与肿瘤相关功能的研究进展 被引量:2

Research Progress in Modified Citrus Pectin on Inhibiting the Tumor-Related Functions of Galectin-3
原文传递
导出
摘要 半乳糖凝集素-3(Gal-3)是半乳糖凝集素家族中唯一一种嵌合体结构蛋白,含有一个特定的糖基识别结构域(CRD),能够特异性识别并结合半乳糖,此结构域可介导细胞与细胞之间的黏附和识别,并且能够促进部分肿瘤细胞的增殖和转移等。改良的橘皮果胶(MCP)可通过特异性结合肿瘤相关蛋白Gal-3糖基识别结构域,抑制Gal-3与其相关肿瘤受体的结合,阻断肿瘤细胞之间相关信号的传导,从而表现出较强的抗肿瘤活性。本文综述了MCP在Gal-3介导肿瘤发生发展过程中相关作用的研究进展。 Galectin-3(Gal-3) is the only chimeric structural protein in the galectin family and contains a specific carbohydrate recognition domain(CRD) that specifically recognizes and binds to galactose. The CRD can mediate cell-to-cell adhesion and recognition. It can also promote the proliferation and metastasis of some tumor cells. By specifically binding to the tumor-associated protein of Gal-3’s CRD, modified citrus pectin(MCP) could inhibit the binding of Gal-3 to its associated tumor receptors and block the transduction of relevant signals between tumor cells, which shows strong anti-tumor activities. This paper reviews the research progress in the role of MCP in Gal-3-mediated tumorigenesis and development.
作者 李仪晴 李小玉 白晶晶 李虎 张涛 Li Yiqing;Li Xiaoyu;Bai Jingjing;Li Hu;Zhang Tao(School of Laboratory Medicine,Zunyi Medical University,Zunyi,563000;Department of Laboratory Medicine,Affiliated Hospital of Zunyi Medical University,Zunyi,563006)
出处 《化学通报》 CAS CSCD 北大核心 2021年第9期895-899,共5页 Chemistry
关键词 改良的橘皮果胶 半乳糖凝集素-3 抗肿瘤 Modified citrus pectin Galectin-3 Antitumor
  • 相关文献

参考文献13

二级参考文献131

共引文献63

同被引文献20

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部